About
NextGen Jane, Inc. is a biotechnology and genomics company based in Oakland, California, founded in 2014 by Ridhi Tariyal and Stephen Gire. The company specializes in women's healthcare, focusing on improving obstetric and gynecological health through innovative molecular insights derived from menstrual blood analysis. NextGen Jane has developed a patented Smart Tampon System that collects menstrual blood samples non-invasively, generating extensive genomic data for longitudinal studies known as the "menstrualome." This technology enables the detection of early markers for reproductive disorders such as endometriosis, uterine fibroids, and polycystic ovarian syndrome, offering a less invasive alternative to traditional diagnostic methods. The company's services aim to enhance diagnostics and treatment options, empowering menstruators to manage their reproductive health proactively. NextGen Jane targets women and menstruators seeking improved diagnostic tools and personalized healthcare for reproductive health conditions. Their approach emphasizes routine data collection to support preventative care and informed decision-making, contributing to advancements in female reproductive health diagnostics and research.
Technologies
Keywords
Company Information
-
Employees 9
-
Founded 2014
-
Annual Revenue $6500000
-
Total Funding $13417234
Location
299 30th St, Oakland, California, United States, 94611
